Todd Asset Management’s Biogen BIIB Stock Holding History

Todd Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-69,793	Closed	-$19.5M	–	219
2021 Q1	$19.5M	Buy	+69,793	New	+$18.8M	0.46%	112
2020 Q2	–	Sell	-47,731	Closed	-$15.1M	–	208
2020 Q1	$15.1M	Sell	47,731 -73,222	-61%	-$22.2M	0.58%	77
2019 Q4	$35.9M	Buy	120,953 +66,115	+121%	+$18.3M	0.89%	30
2019 Q3	$12.8M	Sell	54,838 -148	-0.3%	-$34.5K	0.35%	132
2019 Q2	$12.9M	Sell	54,986 -46,890	-46%	-$10.8M	0.35%	131
2019 Q1	$24.1M	Buy	101,876 +19,110	+23%	+$6.02M	0.68%	53
2018 Q4	$24.9M	Buy	82,766 +4,657	+6%	+$1.49M	0.8%	38
2018 Q3	$27.6M	Buy	78,109 +31,762	+69%	+$10.9M	0.76%	38
2018 Q2	$13.5M	Sell	46,347 -167	-0.4%	-$47K	0.38%	122
2018 Q1	$12.7M	Buy	+46,514	New	+$14.4M	0.35%	133
2017 Q1	–	Sell	-2,068	Closed	-$586K	–	212
2016 Q4	$586K	Sell	2,068 -113	-5%	-$33.5K	0.02%	195
2016 Q3	$683K	Buy	+2,181	New	+$646K	0.02%	190

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Todd Asset Management's BIIB Position: Q2 2021 in Review

Todd Asset Management sold out of Biogen (BIIB) in Q2 2021, closing a stake of 69,793 shares — an estimated $19.5M sold.

Todd Asset Management first reported a position in BIIB in Q3 2016 and held it in 12 quarters. The position peaked at $35.9M in Q4 2019. 1,106 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

Todd Asset Management reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
Todd Asset Management sold 69,793 Biogen shares in Q2 2021, an estimated $19.5M.
Todd Asset Management first reported a position in Biogen in Q3 2016 and held it in 12 quarters.
Todd Asset Management's Biogen position peaked at $35.9M in Q4 2019.
1,106 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Todd Asset Management's 13F filing for Q2 2021, filed 5 Aug 2021.